Results for
"[search-keyword]"
Sponsor content
49 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RELFYDESS relabotulinumtoxinA 100 units/mL solution for injection vial.
-
Australian Public Assessment Report (AusPAR)Sohonos (palovarotene) has been approved to treat heterotopic ossification in individuals with fibrodysplasia ossificans progressiva.
-
Prescription medicine decision summaryRelfydess (relabotulinumtoxinA, purified Botulinum toxin type A) has been approved for the temporary improvement in the appearance of glabellar lines ("frown lines") and lateral canthal lines ("crows feet").
-
Cancellation by sponsorRequested by Ipsen Pty Ltd
-
Cancellation by sponsorRequested by Ipsen Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SOHONOS palovarotene 5 mg capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SOHONOS palovarotene 2.5 mg capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SOHONOS palovarotene 1.5 mg capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SOHONOS palovarotene 1 mg capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SOHONOS palovarotene 10 mg capsule blister pack.